Fauser Bart Cjm, Macklon Nick S
University Medical Center Utrecht and University of Utrecht, Utrecht, The Netherlands.
London Women's Clinic, London, UK..
Reprod Biomed Online. 2025 May 15;51(4):105052. doi: 10.1016/j.rbmo.2025.105052.
The remarkable advances in the efficacy and safety of IVF treatment that have been achieved since the first IVF baby was born in 1978 stand comparison with any other branch of medicine. These advances have continued despite the withdrawal of public investment in clinical reproductive medicine and research, raising a number of questions. How is this global shift from public to largely private sector care provision affecting the quality and direction of research, innovation and clinical training? This Commentary reviews the implications, both positive and less so, for academic reproductive medicine and training, and outline the opportunities that exist to secure the future of the subspeciality and ongoing progress in fertility care in this changing environment.
自1978年首例试管婴儿诞生以来，体外受精（IVF）治疗在疗效和安全性方面取得了显著进展，可与医学的任何其他分支相媲美。尽管公共部门对临床生殖医学和研究的投资减少，但这些进展仍在持续，这引发了一些问题。这种从公共部门到主要由私营部门提供医疗服务的全球转变，对研究、创新和临床培训的质量及方向产生了怎样的影响？本评论文章审视了对学术性生殖医学和培训的积极及不太积极的影响，并概述了在这一不断变化的环境中确保该亚专业的未来以及生育护理持续进步所存在的机遇。
